A detailed history of Seven Eight Capital, LP transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Seven Eight Capital, LP holds 40,413 shares of IART stock, worth $929,499. This represents 0.07% of its overall portfolio holdings.

Number of Shares
40,413
Holding current value
$929,499
% of portfolio
0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$17.14 - $31.74 $692,678 - $1.28 Million
40,413 New
40,413 $734,000
Q1 2024

May 13, 2024

BUY
$33.4 - $45.2 $153,105 - $207,196
4,584 Added 12.36%
41,665 $1.48 Million
Q4 2023

Feb 13, 2024

BUY
$34.21 - $44.59 $1.27 Million - $1.65 Million
37,081 New
37,081 $1.61 Million
Q2 2023

Aug 14, 2023

BUY
$37.95 - $58.98 $645,795 - $1 Million
17,017 New
17,017 $699,000
Q2 2022

Aug 04, 2022

BUY
$53.86 - $66.52 $432,226 - $533,823
8,025 New
8,025 $434,000
Q4 2020

Feb 09, 2021

SELL
$43.31 - $66.55 $480,741 - $738,705
-11,100 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$43.33 - $51.72 $480,963 - $574,092
11,100 New
11,100 $524,000
Q1 2020

May 14, 2020

SELL
$36.67 - $61.04 $193,360 - $321,863
-5,273 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$55.73 - $62.49 $1.52 Million - $1.7 Million
-27,200 Reduced 83.76%
5,273 $307,000
Q3 2019

Nov 14, 2019

BUY
$53.29 - $64.59 $1.52 Million - $1.85 Million
28,600 Added 738.45%
32,473 $1.95 Million
Q2 2019

Aug 12, 2019

SELL
$46.45 - $55.85 $645,655 - $776,315
-13,900 Reduced 78.21%
3,873 $216,000
Q1 2019

May 15, 2019

BUY
$42.97 - $57.33 $763,705 - $1.02 Million
17,773 New
17,773 $990,000

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.92B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.